Rashidi Omran Mohammed, H Nazar Fatima Amanullah, Alama Mohamed Nabil, Awan Zuhier Ahmed
Department of Clinical Biochemistry. Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Biology, Genomic and Biotechnology Section. Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Open Cardiovasc Med J. 2017 Sep 14;11:84-93. doi: 10.2174/1874192401711010084. eCollection 2017.
Apolipoprotein E (APOE) gene is a ligand protein in humans which mediates the metabolism of cholesterol by binding to the low-density lipoprotein receptor (LDLR). P.Leu167del mutation in APOE gene was recently connected with Familial Hypercholesterolemia, a condition associated with premature cardiovascular disease. The consequences of this mutation on the protein structure and its receptor binding capacity remain largely unknown.
The current study aims to further decipher the underlying mechanism of this mutation using advanced software-based algorithms. The consequences of disrupting the leucine zipper by this mutation was studied at the structural and functional level of the APOE protein.
3D protein modeling for both APOE and LDLR (wild types), along with APOE (p.Leu167del) mutant type were generated using homology modeling template-based alignment. Structural deviation analysis was performed to evaluate the spatial orientation and the stability of the mutant APOE structure. Molecular docking analysis simulating APOE-LDLR protein interaction was carried out, in order to evaluate the impact of the mutation on the binding affinity.
Structural deviation analysis for APOE mutated model showed low degree of deviance scoring root-mean-square deviation, (RMSD) = 0.322 Å. Whereas Docking simulation revealed an enhanced molecular interaction towards the LDLR with an estimation of +171.03 kJ/mol difference in binding free energy.
This study suggests that p.Leu167del is causing the protein APOE to associate strongly with its receptor, LDLR. This gain-of-function is likely hindering the ability of LDLR to be effectively recycled back to the surface of the hepatocytes to clear cholesterol from the circulation therefore leading to FH.
载脂蛋白E(APOE)基因是人类中的一种配体蛋白,它通过与低密度脂蛋白受体(LDLR)结合来介导胆固醇的代谢。APOE基因中的P.Leu167del突变最近与家族性高胆固醇血症相关,这是一种与早发性心血管疾病相关的病症。这种突变对蛋白质结构及其受体结合能力的影响在很大程度上仍然未知。
本研究旨在使用先进的基于软件的算法进一步解读这种突变的潜在机制。在APOE蛋白的结构和功能水平上研究这种突变对亮氨酸拉链的破坏后果。
使用基于同源建模模板的比对生成APOE和LDLR(野生型)以及APOE(p.Leu167del)突变型的三维蛋白质模型。进行结构偏差分析以评估突变型APOE结构的空间取向和稳定性。进行模拟APOE-LDLR蛋白质相互作用的分子对接分析,以评估突变对结合亲和力的影响。
APOE突变模型的结构偏差分析显示偏差评分均方根偏差(RMSD)的程度较低,为0.322 Å。而对接模拟显示对LDLR的分子相互作用增强,结合自由能估计相差+171.03 kJ/mol。
本研究表明p.Leu167del导致蛋白质APOE与其受体LDLR强烈结合。这种功能获得可能会阻碍LDLR有效地循环回到肝细胞表面以从循环中清除胆固醇的能力,从而导致家族性高胆固醇血症。